IDENTIFICATION OF THE CAUSES OF MENINGOCOCCAL INFECTION IN CHILDREN AND IMPROVEMENT OF PREVENTIVE MEASURES
Keywords:
meningococcal infection, children, prevention, care, meningitis, sepsis, immunization, bacterial infection, vaccination, epidemiological controlAbstract
Менингококковая инфекция является одной из наиболее тяжело протекающих, быстро развивающихся и опасных для жизни заболеваний у детей. В данной работе уделяется внимание клиническим признакам менингококковой инфекции, ее ранней диагностике, современным методам лечения и мерам профилактики. Кроме того, освещаются основные принципы ухода за детьми, заболевшими менингококковой инфекцией, методы иммунизации и эпидемиологического контроля. Ранняя диагностика и эффективная профилактика значительно снижают показатели смертности и осложнений среди детей.References
1. Acquisition of virulence genes by a carrier strain gave rise to the
ongoing epidemics of meningococcal disease in West Africa / O.B. Brynildsrud, V.
Eldholm, J. Bohlin [et al.] // Proceedings of the National Academy of Sciences. -
2018. - Vol. 115, № 21. - P. 5510-5515.
2. An invasive isolate of Neisseria meningitidis showing decreased
susceptibility to quinolones / T.R. Shultz, J.W. Tapsall, P.A. White [et al.] //
Antimicrobial Agents and Chemotherapy. - 2000. - Vol. 44, № 4. - P. 1116.
3. An overview of meningococcal disease in India: Knowledge gaps and
potential solutions / T.J. John, S. Gupta, A.J. Chitkara [et al.] // Vaccine. - 2013. -
Vol. 31, № 25. - P. 2731-2737.
4. Arreaza, L. Antibiotic susceptibility patterns of Neisseria meningitidis
isolates from patients and asymptomatic carriers / L. Arreaza, L. De La Fuente, J.
Vázquez // Antimicrobial Agents and Chemotherapy. - 2000. - Vol. 44, № 6. - P.
1705-1707.
5. Atkinson, B. History of Meningococcal Outbreaks in the United States:
Implications for Vaccination and Disease Prevention / B. Atkinson, A. Gandhi, P.
Balmer // Pharmacotherapy: The Journal of Human Pharmacology and Drug
Therapy. - 2016. - Vol. 36, № 8. - P. 880-892.
6. Atypical presentation of invasive meningococcal disease caused by
serogroup W meningococci / C. Stinson, C. Burman, J. Presa [et al.] // Epidemiology
and Infection. - 2020. - Vol. 148. - P. e12.
7. Australian Meningococcal Surveillance Programme Annual report of
the Australian Meningococcal Surveillance Programme, 2009 // Communicable
diseases intelligence. - 2010. - Vol. 34, № 3. - P. 291-302.
8. Bakir, M. Meningococcal serogroup B disease in Turkey: A guess or
reality? / M. Bakir // Human Vaccines and Immunotherapeutics. - 2014. - Vol. 10,
№ 6. - P. 1721-1724.
9. Barnett, E.D. Role of Immigrants and Migrants in Emerging Infectious
Diseases / E.D. Barnett, P.F. Walker // Medical Clinics of North America. - 2008. -
Vol. 92, № 6. - P. 1447-1458.
10. Case fatality rates of invasive meningococcal disease by serogroup and
age: A systematic review and meta-analysis / B. Wang, R. Santoreneos, L. Giles [et
al.] Vaccine. - 2019. - Vol. 37, № 21. - P. 2768-2782.